Unifying CRM and EWOC designs for phase I cancer clinical trials (Q1007501)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Unifying CRM and EWOC designs for phase I cancer clinical trials |
scientific article; zbMATH DE number 5530775
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Unifying CRM and EWOC designs for phase I cancer clinical trials |
scientific article; zbMATH DE number 5530775 |
Statements
Unifying CRM and EWOC designs for phase I cancer clinical trials (English)
0 references
20 March 2009
0 references
phase I cancer clinical trial
0 references
maximum tolerated dose
0 references
dose-limiting toxicity
0 references
continual reassessment method
0 references
escalation with overdose control
0 references
0 references
0.8059906363487244
0 references
0.7908891439437866
0 references
0.7875670194625854
0 references
0.7661763429641724
0 references
0.7511611580848694
0 references
